An observational, multinational, multi-center, prospective, open-label study to assess effectiveness, safety and tolerability in patients with arterial hypertension receiving aliskiren or aliskiren HCT in a real-world setting.

Trial Profile

An observational, multinational, multi-center, prospective, open-label study to assess effectiveness, safety and tolerability in patients with arterial hypertension receiving aliskiren or aliskiren HCT in a real-world setting.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs ACE inhibitors; Aliskiren; Aliskiren/hydrochlorothiazide; Angiotensin receptor antagonists; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Diuretics
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms AHEAD
  • Sponsors Novartis
  • Most Recent Events

    • 25 Aug 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top